Alkeon Capital Management LLC Trims Position in BioCryst Pharmaceuticals, Inc. $BCRX

AI Briefing

• – Alkeon Capital Management LLC decreased its position in BioCryst Pharmaceuticals, Inc. by 4.4% during the third quarter.
• – The firm owned 5,464,021 shares of the biotechnology company's stock after selling 250,000 shares.
• – BioCryst Pharmaceuticals, Inc. stock is owned by Alkeon Capital Management LLC.